KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Gilead Sciences (GILD) Revenue (2016 - 2025)

Historic Revenue for Gilead Sciences (GILD) over the last 17 years, with Q3 2025 value amounting to $7.8 billion.

  • Gilead Sciences' Revenue rose 296.89% to $7.8 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $29.1 billion, marking a year-over-year increase of 278.46%. This contributed to the annual value of $28.8 billion for FY2024, which is 604.07% up from last year.
  • According to the latest figures from Q3 2025, Gilead Sciences' Revenue is $7.8 billion, which was up 296.89% from $7.1 billion recorded in Q2 2025.
  • Gilead Sciences' 5-year Revenue high stood at $7.8 billion for Q3 2025, and its period low was $6.2 billion during Q2 2021.
  • Moreover, its 5-year median value for Revenue was $7.0 billion (2022), whereas its average is $6.9 billion.
  • As far as peak fluctuations go, Gilead Sciences' Revenue skyrocketed by 2088.28% in 2021, and later plummeted by 510.71% in 2022.
  • Over the past 5 years, Gilead Sciences' Revenue (Quarter) stood at $7.2 billion in 2021, then rose by 2.0% to $7.4 billion in 2022, then decreased by 3.72% to $7.1 billion in 2023, then grew by 6.4% to $7.6 billion in 2024, then increased by 2.64% to $7.8 billion in 2025.
  • Its last three reported values are $7.8 billion in Q3 2025, $7.1 billion for Q2 2025, and $6.7 billion during Q1 2025.